U-Lace and FRAXA Partner to Find a Cure for the Most Common Inherited Cause of Autism

Share Article

U-Lace and FRAXA Research Foundation forge new partnership during Autism Awareness month. The no-tie shoelace company and nonprofit’s collaboration will help fund research for treatment and a cure of fragile X syndrome, the most common inherited cause of autism.

News Image
"We simply embraced the community and continued to ask how can we help more, and how can we make the product better for these incredible kids? FRAXA was an obvious choice for all the work they do,” said U-Lace Founder and CEO Tim Talley.

U-Lace and FRAXA Research Foundation announced a new partnership today, to help find a cure for the most common inherited cause of autism.

FRAXA’s mission is to find treatments and ultimately, a cure for fragile X syndrome. Fragile X, or FXS, is a genetic condition that causes intellectual disability, behavioral and learning challenges and various physical characteristics. It is the most common known inherited cause of autism worldwide.

U-Lace, creator of the modular no-tie shoelace category and the global product leader in the category, has been adopted by many in the autism community as a life-changing product. Parents have written the company sharing that U-Lace, “gives children a sense of pride, normalcy and self-accomplishment.”

The partnership with FRAXA begins with special affiliate marketing programs and the development of custom, FRAXA co-branded U-Laces. The Special FRAXA Packs will be sold on both the FRAXA.org site and the U-Lace.com site with a minimum of 20% of sales going to fund FRAXA research efforts.

“We are thrilled to be partnering with U-Lace. While we get closer to finding effective treatments for fragile X, we are always on the lookout for ways to make our children's lives easier and happier," said President Katie Clapp, MS. Clapp co-founded the organization after her son, Andy, was diagnosed with FXS. “U-Lace has been open to all ideas and is committed to being a part of finding a cure for autism, so we are grateful they are now committed to the fragile X community.”

Said U-Lace Founder and CEO Tim Talley, “I wish we were smart enough to have known how much of a life-changing product U-Lace would be in the autism community. The autism community found us and began telling us how much they loved the product. Kids slip on sneakers easily and fit in with their friends wearing real laces, not Velcro or plastic. Some of the notes we’ve received are true tear-jerkers. We simply embraced the community and continued to ask how can we help more, and how can we make the product better for these incredible kids? FRAXA was an obvious choice for all the work they do.”

About U-Lace: U-Lace is a global modular no-tie lace brand. Since being featured on Shark Tank in 2014 and gaining investment from Mark Cuban, U-Lace has grown into a successful business which brings innovative products to the previously-limited shoelace industry. Its no-tie laces have sold over 12 million sets worldwide.

About FRAXA: The Massachusetts-based nonprofit has funded more than $27 million in biomedical research, yielding discoveries that are changing the lives of families coping with fragile X. Three Nobel Laureates sit on their volunteer Scientific Advisory Board.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tim Talley
U-Lace
716-848-0939
Email >
Visit website